Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2008;336:405 (23 February), doi:10.1136/bmj.39493.447361.1F
| The first 150 words of the full text of this article appear below. |
Drug companies market drugs for BPH (benign prostatic hyperplasia). However, this is a misuse of the term, which all dictionaries define as a histological term and not related to gross anatomical change. It is therefore disappointing that the BMJ has commissioned review articles on BPH .1 Several important organisations have accepted the arguments presented in the BMJ in 1994, that the term LUTS (lower urinary tract symptoms) should be used rather than "prostatism," and now "storage" and "voiding" symptoms are the preferred terms to "irritative" and "obstructive" symptoms.2 3 4 5 However, these organisations also supported the proposal for the proper use of the terms BPH (histology), BPE (enlargement), and BPO (obstruction).5
Using the correct terminology (BPH, BPE, BPO) is likely to protect men from inappropriate treatment and help ensure that care is focused on the cause of their LUTS.
All men have prostates, and if they live long enough they will get
Paul Abrams, professor of urology
1 Bristol Urological Institute, Southmead Hospital, Bristol BS10 5NB
paul_abrams@bui.ac.uk
Read all Rapid Responses